Aranesp is a medication usually given by injection to treat anemia resulting from chronic kidney failure or associated with chemotherapy. It stimulates the bone marrow to produce new red blood cells, which helps raise hemoglobin levels in the blood and improve oxygen transport to the body's various tissues. This reduces the constant feeling of fatigue and exhaustion and increases the patient's ability to perform daily activities normally and stably.
Aranesp is also an effective treatment that reduces the patient's need for repeated blood transfusions and helps control bothersome symptoms such as shortness of breath, dizziness, and poor concentration. With regular use under close medical supervision, it can lead to a significant improvement in quality of life and enhance activity and vitality in the long term, making it an essential part of the treatment plan for patients with chronic anemia associated with kidney disease or cancer treatments.